Salabati M, Obeid A, Mahmoudzadeh R, Gupta O, et al. Outcomes after switching eyes that were stable on aflibercept to ranibizumab versus continuing aflibercept in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2022 Mar 1. pii: 10.1007/s00417-022-05601.
PMID: 35230472